Advertisement
trendingNowenglish2437947https://zeenews.india.com/india/covaxin-to-be-evaluated-as-covid-19-vaccine-candidate-in-us-bharat-biotech-2437947.html

Covaxin to be evaluated as Covid-19 vaccine candidate in US: Bharat Biotech

US Food and Drug Administration (FDA) has lifted its clinical hold on the Ocugen, Inc Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States. 

Covaxin to be evaluated as Covid-19 vaccine candidate in US: Bharat Biotech Image credit: ANI

Hyderabad: Hyderabad-based Bharat Biotech on Saturday (February 19) said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.

"Ocugen, Inc (NASDAQ: OCGN) announced that the US Food and Drug Administration (FDA) has lifted its clinical hold on the Company`s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States. Ocugen, Inc is co-developing Bharat Biotech`s Covaxin vaccine candidate for COVID-19 in USA and Canada," read Bharat Biotech`s statement.

Earlier the Ministry of Health and Family Welfare had informed that Covaxin has been granted approval for emergency use in 13 countries as of January 31, 2022. 
 

Live TV

Live TV

Stay informed on all the latest news, real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.

NEWS ON ONE CLICK